These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27133695)

  • 1. Diffusion tensor imaging in the normal breast: influences of fibroglandular tissue composition and background parenchymal enhancement.
    Plaza MJ; Morris EA; Thakur SB
    Clin Imaging; 2016; 40(3):506-11. PubMed ID: 27133695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast MRI during lactation: effects on tumor conspicuity using dynamic contrast-enhanced (DCE) in comparison with diffusion tensor imaging (DTI) parametric maps.
    Nissan N; Allweis T; Menes T; Brodsky A; Paluch-Shimon S; Haas I; Golan O; Miller Y; Barlev H; Carmon E; Brodsky M; Anaby D; Lawson P; Halshtok-Neiman O; Shalmon A; Gotlieb M; Faermann R; Konen E; Sklair-Levy M
    Eur Radiol; 2020 Feb; 30(2):767-777. PubMed ID: 31529255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.
    Leithner D; Baltzer PA; Magometschnigg HF; Wengert GJ; Karanikas G; Helbich TH; Weber M; Wadsak W; Pinker K
    J Nucl Med; 2016 Oct; 57(10):1518-1522. PubMed ID: 27230924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging.
    King V; Kaplan J; Pike MC; Liberman L; David Dershaw D; Lee CH; Brooks JD; Morris EA
    Breast J; 2012; 18(6):527-34. PubMed ID: 23002953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.
    Vreemann S; Dalmis MU; Bult P; Karssemeijer N; Broeders MJM; Gubern-Mérida A; Mann RM
    Eur Radiol; 2019 Sep; 29(9):4678-4690. PubMed ID: 30796568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue.
    Price ER; Brooks JD; Watson EJ; Brennan SB; Comen EA; Morris EA
    Eur Radiol; 2014 Jan; 24(1):162-8. PubMed ID: 23982290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of fibroglandular tissue and background parenchymal enhancement on diffusion weighted imaging of breast lesions.
    Iacconi C; Thakur SB; Dershaw DD; Brooks J; Fry CW; Morris EA
    Eur J Radiol; 2014 Dec; 83(12):2137-2143. PubMed ID: 25445896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully automatic quantification of fibroglandular tissue and background parenchymal enhancement with accurate implementation for axial and sagittal breast MRI protocols.
    Wei D; Jahani N; Cohen E; Weinstein S; Hsieh MK; Pantalone L; Kontos D
    Med Phys; 2021 Jan; 48(1):238-252. PubMed ID: 33150617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
    King V; Goldfarb SB; Brooks JD; Sung JS; Nulsen BF; Jozefara JE; Pike MC; Dickler MN; Morris EA
    Radiology; 2012 Sep; 264(3):670-8. PubMed ID: 22771878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Background parenchymal enhancement and fibroglandular tissue on breast MRI in women with high genetic risk: Are changes before and after risk-reducing salpingo-oophorectomy associated with breast cancer risk?
    Bermot C; Saint-Martin C; Malhaire C; Sebbag-Sfez D; Mouret-Fourme E; Carton M; Thibault FE
    Eur J Radiol; 2018 Dec; 109():171-177. PubMed ID: 30527300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.
    King V; Gu Y; Kaplan JB; Brooks JD; Pike MC; Morris EA
    Eur Radiol; 2012 Dec; 22(12):2641-7. PubMed ID: 22752463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.
    Sung JS; Corben AD; Brooks JD; Edelweiss M; Keating DM; Lin C; Morris EA; Patel P; Robson M; Woods M; Bernstein JL; Pike MC
    Breast Cancer Res Treat; 2018 Nov; 172(2):487-496. PubMed ID: 30140962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
    Bennani-Baiti B; Dietzel M; Baltzer PA
    PLoS One; 2016; 11(7):e0158573. PubMed ID: 27379395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully Automatic Assessment of Background Parenchymal Enhancement on Breast MRI Using Machine-Learning Models.
    Nam Y; Park GE; Kang J; Kim SH
    J Magn Reson Imaging; 2021 Mar; 53(3):818-826. PubMed ID: 33219624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulated echo diffusion tensor imaging (STEAM-DTI) with varying diffusion times as a probe of breast tissue.
    Teruel JR; Cho GY; Moccaldi Rt M; Goa PE; Bathen TF; Feiweier T; Kim SG; Moy L; Sigmund EE
    J Magn Reson Imaging; 2017 Jan; 45(1):84-93. PubMed ID: 27441890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of contrast enhancement and diffusion-weighted magnetic resonance imaging in healthy and cancerous breast tissue.
    Cho GY; Moy L; Kim SG; Klautau Leite AP; Baete SH; Babb JS; Sodickson DK; Sigmund EE
    Eur J Radiol; 2015 Oct; 84(10):1888-93. PubMed ID: 26220915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Background Parenchymal Enhancement and Fibroglandular Tissue Proportion on Breast MRI: Correlation with Hormone Receptor Expression and Molecular Subtypes of Breast Cancer.
    Öztürk M; Polat AV; Süllü Y; Tomak L; Polat AK
    J Breast Health; 2017 Jan; 13(1):27-33. PubMed ID: 28331765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.
    Wu S; Weinstein SP; DeLeo MJ; Conant EF; Chen J; Domchek SM; Kontos D
    Breast Cancer Res; 2015 May; 17():67. PubMed ID: 25986460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI Texture Analysis of Background Parenchymal Enhancement of the Breast.
    Amano Y; Woo J; Amano M; Yanagisawa F; Yamamoto H; Tani M
    Biomed Res Int; 2017; 2017():4845909. PubMed ID: 28812015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Background parenchymal enhancement at breast MR imaging and breast cancer risk.
    King V; Brooks JD; Bernstein JL; Reiner AS; Pike MC; Morris EA
    Radiology; 2011 Jul; 260(1):50-60. PubMed ID: 21493794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.